Butterfly Medical

Benign Prostatic Hyperplasia (BPH) is the non-cancerous enlargement of the prostate, affecting almost all men as they age. Majority of patients who fail or do not tolerate drug treatment, undergo a surgical procedure that carries risks and side-effects.Butterfly Medical is developing a novel dilation device, delivered in the office-setting in a matter of minutes offering patients immediate relief.Current reimbursement codes (CPT) offer significantly higher payment for office-based procedures, making the Butterfly device an opportunity for physicians to treat more patients and make higher profits per patient. We have a fully developed product and several pre-clinical trials showing great results.We are in process to initiate clinical trials in early 2016 and gain European marketing approval by mid-2016.We have done all that within the first year of operation!